Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
暂无分享,去创建一个
Maximilian Reiser | Christiane Kuhl | Walter Heindel | Bernd Tombach | Simone Schrading | Hans H Schild | C. Kuhl | M. Reiser | W. Heindel | C. Leutner | H. Schild | H. Bieling | S. Schrading | B. Tombach | Stefanie Weigel | Birke Arand | Heribert Bieling | Roy König | Claudia Leutner | Andrea Rieber-Brambs | Dennis Nordhoff | S. Weigel | A. Rieber-Brambs | B. Arand | D. Nordhoff | R. König
[1] G. Brix,et al. Strahlenrisiko infolge von Mammographie-Screening-Untersuchungen für Frauen unter 50 Jahren , 2008 .
[2] J R Griffiths,et al. Clinical studies. , 2005, Advances in pharmacology.
[3] D. Berry,et al. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.
[4] Constantine Gatsonis,et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging , 2005, Cancer.
[5] D. Stoppa-Lyonnet,et al. Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] L. Liberman,et al. Determination of the Presence and Extent of Pure Ductal Carcinoma in Situ by Mammography and Magnetic Resonance Imaging , 2005, The breast journal.
[7] Peter C Gøtzsche,et al. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends , 2009, BMJ : British Medical Journal.
[8] R. Fimmers,et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Giovanni Parmigiani,et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] P. V. van Diest,et al. BRCA1 and BRCA2 germline mutation analysis in the Indonesian population , 2007, Breast Cancer Research and Treatment.
[11] G. Giles,et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations , 1998, Cancer.
[12] D. Easton,et al. Risk prediction models for familial breast cancer. , 2006, Future oncology.
[13] W. Foulkes,et al. A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors , 2005, Cancer Epidemiology Biomarkers & Prevention.
[14] L. Esserman,et al. Genetic/familial high-risk assessment , 2010 .
[15] Ellen Warner,et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.
[16] Kevin Hughes,et al. Predicting the survival of patients with breast carcinoma using tumor size , 2002, Cancer.
[17] R. A’Hern,et al. The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography? , 2001, European journal of cancer.
[18] V. Kataja,et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. , 2004, JAMA.
[19] J. Satagopan,et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] H. D. de Koning,et al. Hereditary breast cancer growth rates and its impact on screening policy. , 2005, European journal of cancer.
[21] Laura Cortesi,et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. , 2007, Radiology.
[22] G. Parker,et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.
[23] Ingvar Andersson,et al. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study , 2006, BMJ : British Medical Journal.
[24] Barbara L. Smith,et al. The effect of tumor size and lymph node status on breast carcinoma lethality , 2003, Cancer.
[25] Edna Schechtman,et al. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions , 2005, Cancer.
[26] Edward Ashton,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2012, Definitions.
[27] U. P. S. T. Force. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement , 2005, Annals of Internal Medicine.
[28] Jean B. Cormack,et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. , 2008, JAMA.
[29] N. Hylton,et al. Magnetic resonance imaging of the breast prior to biopsy. , 2004, JAMA.
[30] K Offit,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.
[31] Simone Schrading,et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study , 2007, The Lancet.
[32] J. Klijn,et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] E. Lynge,et al. Breast cancer incidence after the introduction of mammography screening , 2006, Cancer.
[34] Ying Lu,et al. Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. , 2008, Radiology.
[35] E. Lustbader,et al. Validation of a breast cancer risk assessment model in women with a positive family history. , 1994, Journal of the National Cancer Institute.
[36] Kjell Arne Kvistad,et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. , 2007, Breast.
[37] N. Hylton,et al. Improved tumor vascular function following high‐dose epidermal growth factor receptor tyrosine kinase inhibitor therapy , 2007, Journal of magnetic resonance imaging : JMRI.
[38] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .
[39] A. Trentham-Dietz,et al. Familial relative risk estimates for use in epidemiologic analyses. , 2006, American journal of epidemiology.
[40] A. Ellis. Breast , 2002, BMJ : British Medical Journal.
[41] Daniel F Chen,et al. Magnetic resonance imaging captures the biology of ductal carcinoma in situ. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .
[43] G M Lenoir,et al. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.
[44] A. Meindl,et al. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population , 2002, International journal of cancer.
[45] N. Hylton. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] Erik Holmberg,et al. Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts , 2002, Radiation research.
[47] Theo van der Kwast,et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammography , 2002, International journal of cancer.
[48] R. Macmillan. Screening women with a family history of breast cancer--results from the British Familial Breast Cancer Group. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[49] H. D. de Koning,et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.
[50] L. Tabár,et al. Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer , 2005, Breast Cancer Research.
[51] J. Chang-Claude,et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[53] R Holland,et al. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of Oncology.
[54] D Krebs,et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. , 2000, Radiology.
[55] J. Austoker,et al. What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] K. Offit,et al. Clinical practice. Management of an inherited predisposition to breast cancer. , 2007, The New England journal of medicine.
[57] F. Alexander,et al. Screening Status in Relation to Biological and Chronological Characteristics of Breast Cancers: A Cross Sectional Survey , 1997, Journal of medical screening.
[58] J. Marks,et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] M. Stratton,et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.
[60] C. Kuhl,et al. Mammographic, US, and MR imaging phenotypes of familial breast cancer. , 2008, Radiology.
[61] J. Klijn,et al. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study , 2007, Breast Cancer Research.
[62] A. Hackshaw,et al. EUSOMA review of mammography screening. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[63] Emily White,et al. Factors contributing to mammography failure in women aged 40-49 years. , 2004, Journal of the National Cancer Institute.
[64] A. Berrington de González,et al. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits , 2005, British Journal of Cancer.
[65] Karla Kerlikowske,et al. Performance benchmarks for screening mammography. , 2006, Radiology.
[66] Yu Shen,et al. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. , 2005, Journal of the National Cancer Institute.
[67] Ying Lu,et al. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. , 2007, Magnetic resonance imaging.
[68] Mark Robson,et al. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. , 2009, Journal of the National Cancer Institute.
[69] L. Norton,et al. BRCA-associated breast cancer in young women. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] R. Eeles,et al. An audit of screening for familial breast cancer before 50 years in the South Thames Region – have we got it right? , 2004, Familial Cancer.